165 related articles for article (PubMed ID: 38249115)
21. Erdheim-Chester disease: expanding the spectrum of cutaneous manifestations.
Kobic A; Shah KK; Schmitt AR; Goyal G; Go RS; Guo R; Rech KL; Sartori-Valinotti JC;
Br J Dermatol; 2020 Feb; 182(2):405-409. PubMed ID: 31120137
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Neuroimaging Manifestations of Erdheim-Chester Disease: A Review.
Garg N; Lavi ES
J Neuroimaging; 2021 Jan; 31(1):35-44. PubMed ID: 32920940
[TBL] [Abstract][Full Text] [Related]
23. Erdheim-chester disease.
Kim MS; Kim CH; Choi SJ; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Ann Dermatol; 2010 Nov; 22(4):439-43. PubMed ID: 21165216
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic involvement in Erdheim-Chester disease: Rare presentation of a rare disease.
Rafiee MJ; Taylor J; Hickeson M; Friedrich MG; Chetrit M
Radiol Case Rep; 2023 May; 18(5):1809-1820. PubMed ID: 36915608
[TBL] [Abstract][Full Text] [Related]
25. Rare Case of a Patient With Erdheim-Chester Disease Presenting With Atypical Breast Involvement.
Sprenger F; Pecorari AG; Filho VV; Kluppel ST; Staats AC
J Breast Cancer; 2024 Apr; 27(2):141-146. PubMed ID: 38233339
[TBL] [Abstract][Full Text] [Related]
26. [Recurrent pericardial effusion as first manifestation of Erdheim-Chester disease].
Lutz SZ; Schmalzing M; Vogel-Claussen J; Adam P; May AE
Dtsch Med Wochenschr; 2011 Sep; 136(39):1952-6. PubMed ID: 21935854
[TBL] [Abstract][Full Text] [Related]
27. The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease.
Dai JW; Lin H; Chang L; Li J; Zhou DB; Cao XX
Ann Hematol; 2023 Dec; 102(12):3335-3343. PubMed ID: 37922006
[TBL] [Abstract][Full Text] [Related]
28. Erdheim-Chester disease: a rare cause of paraplegia.
Curgunlu A; Karter Y; Oztürk A
Eur J Intern Med; 2003 Feb; 14(1):53-55. PubMed ID: 12554012
[TBL] [Abstract][Full Text] [Related]
29. Urologic Manifestations and Hydronephrosis as Initial Presentation of Erdheim-Chester Disease: A Rare Form of Non-Langerhans Histiocytosis.
Burke SE; Chaudhry A; Kaya EA; Schuppe KC; Thomas C; Pearce SM; Mroch H
Cureus; 2021 Nov; 13(11):e19750. PubMed ID: 34938627
[TBL] [Abstract][Full Text] [Related]
30. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
31. Patterns and organ treatment response of Erdheim-Chester disease with cardiac involvement.
Miao HL; Chang L; Lin H; Liu ZZ; Wu W; Niu N; Cao XX
Heart; 2024 Jun; 110(13):899-907. PubMed ID: 38772574
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular manifestations of Erdheim-Chester disease: A narrative review with two cases.
Wong A; Sharma A; Ramcharitar R
Vasc Med; 2024 Jun; 29(3):313-319. PubMed ID: 38469821
[TBL] [Abstract][Full Text] [Related]
33. Erdheim-Chester disease with multisystem involvement evaluated by multimodal imaging: A case report.
Liu J; Gao L; Pu H; He W; Peng L
Radiol Case Rep; 2022 Mar; 17(3):784-789. PubMed ID: 35024076
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review.
Haroche J; Amoura Z; Dion E; Wechsler B; Costedoat-Chalumeau N; Cacoub P; Isnard R; Généreau T; Wechsler J; Weber N; Graef C; Cluzel P; Grenier P; Piette JC
Medicine (Baltimore); 2004 Nov; 83(6):371-392. PubMed ID: 15525849
[TBL] [Abstract][Full Text] [Related]
35. Prevalence, patterns and outcomes of cardiac involvement in Erdheim-Chester disease.
Azoulay LD; Bravetti M; Cohen-Aubart F; Emile JF; Seilhean D; Plu I; Charlotte F; Waintraub X; Carrat F; Amoura Z; Cluzel P; Haroche J
Eur Heart J; 2023 Jul; 44(26):2376-2385. PubMed ID: 36545799
[TBL] [Abstract][Full Text] [Related]
36. Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.
Váradi Z; Bánusz R; Csomor J; Kállay K; Varga E; Kertész G; Csóka M
Onco Targets Ther; 2017; 10():521-526. PubMed ID: 28182116
[TBL] [Abstract][Full Text] [Related]
37. Oral Findings of Erdheim-Chester Disease: A Case Report and Review of the Literature.
Sorenson AD; Emam HA
J Oral Maxillofac Surg; 2021 Jun; 79(6):1287-1291. PubMed ID: 33582038
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis and Treatment of Erdheim-Chester Disease -Review].
Wang JS; Wang Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1256-9. PubMed ID: 27531811
[TBL] [Abstract][Full Text] [Related]
39. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
Kim S; Lee M; Shin HJ; Lee J; Suh YL
Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
[TBL] [Abstract][Full Text] [Related]
40. Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib.
Salama H; Fahed Alzayed M; Alharbi KG; Khattak Z; Omer MH; Tahir L; ALhejazi A
Am J Case Rep; 2022 Feb; 23():e935090. PubMed ID: 35171900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
